HK1223631A1 - 預防和治療炎症的小分子多肽及其應用 - Google Patents

預防和治療炎症的小分子多肽及其應用

Info

Publication number
HK1223631A1
HK1223631A1 HK16111762.5A HK16111762A HK1223631A1 HK 1223631 A1 HK1223631 A1 HK 1223631A1 HK 16111762 A HK16111762 A HK 16111762A HK 1223631 A1 HK1223631 A1 HK 1223631A1
Authority
HK
Hong Kong
Prior art keywords
preventing
low molecular
treating inflammation
molecular polypeptide
polypeptide
Prior art date
Application number
HK16111762.5A
Other languages
English (en)
Inventor
許迅
王莉莉
徐藝
Original Assignee
Shanghai First Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai First Peoples Hospital filed Critical Shanghai First Peoples Hospital
Publication of HK1223631A1 publication Critical patent/HK1223631A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK16111762.5A 2013-08-15 2016-10-12 預防和治療炎症的小分子多肽及其應用 HK1223631A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310357596.6A CN104371003A (zh) 2013-08-15 2013-08-15 预防和治疗炎症的小分子多肽及其应用
PCT/CN2014/084293 WO2015021924A1 (zh) 2013-08-15 2014-08-13 预防和治疗炎症的小分子多肽及其应用

Publications (1)

Publication Number Publication Date
HK1223631A1 true HK1223631A1 (zh) 2017-08-04

Family

ID=52468064

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111762.5A HK1223631A1 (zh) 2013-08-15 2016-10-12 預防和治療炎症的小分子多肽及其應用

Country Status (5)

Country Link
US (1) US10501511B2 (zh)
EP (1) EP3040343B1 (zh)
CN (1) CN104371003A (zh)
HK (1) HK1223631A1 (zh)
WO (1) WO2015021924A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018215245B2 (en) * 2017-02-06 2024-07-11 Resiliun B.V. Interaction between C-peptides and elastin receptor, a model for understanding vascular disease
CN111606974B (zh) * 2019-02-25 2024-08-02 上海市第一人民医院 抑制眼部自身免疫性炎症反应的靶向生物肽的筛选及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148950A1 (en) 2001-10-09 2003-08-07 Li Xin Kringle domain 1 of human hepatocyte growth factor and uses therefor
FR2971509B1 (fr) * 2011-02-16 2013-02-22 Centre Nat Rech Scient Procede de preparation de peptides par assemblage de multiples fragments peptidiques
CN102827253B (zh) * 2011-06-17 2017-07-21 上海市第一人民医院 一种抑制炎症反应的小分子多肽及其应用
WO2013091164A1 (zh) * 2011-12-19 2013-06-27 上海市第一人民医院 预防和抑制炎症的小分子多肽及其应用
CN103897034B (zh) * 2012-12-27 2017-03-15 上海市第一人民医院 一种预防和/或治疗炎症反应的小分子多肽及其应用

Also Published As

Publication number Publication date
WO2015021924A1 (zh) 2015-02-19
US20170037099A1 (en) 2017-02-09
US10501511B2 (en) 2019-12-10
EP3040343B1 (en) 2021-01-20
EP3040343A4 (en) 2017-03-22
CN104371003A (zh) 2015-02-25
EP3040343A1 (en) 2016-07-06

Similar Documents

Publication Publication Date Title
IL267681B (en) Selective grp94 inhibitors and their uses
HK1220355A1 (zh) 抑制劑和其用途
EP2999421A4 (en) CRYOGENIC TREATMENT SYSTEMS
EP2999691A4 (en) Cryopyrin inhibitors for preventing and treating inflammation
GB201314312D0 (en) Composition and delivery system
HRP20190435T1 (hr) Metoda i smjese za zacjeljivanje rana
PL3058936T3 (pl) Kompozycja peptydów i jej zastosowania
HRP20181705T1 (hr) Antimikrobni peptid i njegove uporabe
EP3066472A4 (en) Compositions and methods for detecting and/or treating inflammation
HK1222399A1 (zh) 具有抗衰老功效的肽及其用途
HK1223631A1 (zh) 預防和治療炎症的小分子多肽及其應用
IL246185A0 (en) Methods and compositions for treating dysregulation in systems
HK1208360A1 (zh) 創傷癒合組合物及其用途
EP3085710A4 (en) Protein and use thereof in treating multiple sclerosis
EP3015549A4 (en) NOVEL POLYPEPTIDE AND USE THEREOF
Macdonald Molecular Engineering in Inflammation and Healing
ZA201408732B (en) Composition and methods for treating wounds
ZA201505925B (en) Wound dressing sealant and use thereof
EP3006564A4 (en) NEW PEPTIDE AND ITS USE
GB201309662D0 (en) Wound dressing sealant and use thereof
GB201309709D0 (en) Wound dressing sealant and use thereof